化学研究与应用
化學研究與應用
화학연구여응용
CHEMICAL RESEARCH AND APPLICATION
2014年
5期
707-709
,共3页
江砚芳%许欣%龚曼琳%李贻娟%黄洁%黄亚洁%徐武%张燕
江硯芳%許訢%龔曼琳%李貽娟%黃潔%黃亞潔%徐武%張燕
강연방%허흔%공만림%리이연%황길%황아길%서무%장연
合并血浆%检测试剂%临界值
閤併血漿%檢測試劑%臨界值
합병혈장%검측시제%림계치
pool plasma%test kits%cut-off limit
确保合并血浆检测结果的判定准确可靠,能够有效保证合并血浆的病毒安全性,对合并血浆乙型肝炎病毒表面抗原、丙型肝炎病毒抗体、人类免疫缺陷病毒抗体检测时不同厂家检测试剂的临界值进行确定。(1)使用双抗体夹心酶联免疫法对合并血浆HBsAg和HIV-1/HIV-2抗体的检测临界值进行确定。(2)使用酶联免疫法检测合并血浆HCV抗体的临界值进行确定。经检测和计算,两个厂家检测试剂的检测临界值系数分别为乙型肝炎病毒表面抗原23.398%和26.845%、丙型肝炎病毒抗体9.012%和16.481%、人类免疫缺陷病毒抗体20.025%和23.424%。
確保閤併血漿檢測結果的判定準確可靠,能夠有效保證閤併血漿的病毒安全性,對閤併血漿乙型肝炎病毒錶麵抗原、丙型肝炎病毒抗體、人類免疫缺陷病毒抗體檢測時不同廠傢檢測試劑的臨界值進行確定。(1)使用雙抗體夾心酶聯免疫法對閤併血漿HBsAg和HIV-1/HIV-2抗體的檢測臨界值進行確定。(2)使用酶聯免疫法檢測閤併血漿HCV抗體的臨界值進行確定。經檢測和計算,兩箇廠傢檢測試劑的檢測臨界值繫數分彆為乙型肝炎病毒錶麵抗原23.398%和26.845%、丙型肝炎病毒抗體9.012%和16.481%、人類免疫缺陷病毒抗體20.025%和23.424%。
학보합병혈장검측결과적판정준학가고,능구유효보증합병혈장적병독안전성,대합병혈장을형간염병독표면항원、병형간염병독항체、인류면역결함병독항체검측시불동엄가검측시제적림계치진행학정。(1)사용쌍항체협심매련면역법대합병혈장HBsAg화HIV-1/HIV-2항체적검측림계치진행학정。(2)사용매련면역법검측합병혈장HCV항체적림계치진행학정。경검측화계산,량개엄가검측시제적검측림계치계수분별위을형간염병독표면항원23.398%화26.845%、병형간염병독항체9.012%화16.481%、인류면역결함병독항체20.025%화23.424%。
Assurance the result exact and reliable for pool plasma analysis for decrease the risk of virus infection. Using test kits from different vendor to determine of a cut-off limit for virus mark detecting in pool plasma samples. The double-antibody sandwich ELISA technique was used for HBsAg and anti-HIV-1/HIV-2 test. The ELISA technique was used for anti-HCV test. The HBsAg cut-off limits for virus mark detecting of two vendor kits are 23. 398%and 26. 845%, The anti-HIV-1/HIV-2 cut-off limits are 20. 025%and 23. 424%,The anti-HCV cut-off limits are 9. 012%and 16. 481%. Cut-off limits of two vendor’ s test kits were deter-mined,and the limits can be used to judge detecting results of pool plasma samples.